HANDLING OF MARKET COMPLAINTS AND RECALLS, REVIEW OF FDA-483 FORM
DOI:
https://doi.org/10.22270/ajprd.v6i3.369Keywords:
transportation, patient compliance, Product complaintAbstract
In the pharmaceutical industry, any type of immediate response to the customer complaint can be critical because any product failure can be fatal situation for customer. Product complaint management is critical but essential component in the pharmaceutical industry from the point of view of regulatory and patient compliance. Once, the product get into market, the post marketing surveillance will start its role to monitor the adverse effect on population. The origin of complaint can be anything, like production, transportation and packing. This critical step needs uniform, single, and secured platform to manage product complaint right from initiation to the closure. Hence, the market complaints are handled with well defined procedure on higher priority. If the complaint is genuine, then a root cause analysis performed to rectify the problem and the product should be recalled from market if it is necessary. The main contributions of this paper will be to describe the concerns about the handling of market complaint, effective product recall and rule called as FDA - 483.
Downloads
References
2. Dr Lembit R. Future challenges and opportunities medicines regulation World Health organization geneva, Switzerland‐mail: ragol@who.int
3. Giesen G.N.: Investigations, Complaints and Complaint Food and Drug Administration
4. Office of Regulatory affairs dallas District Office
5. Asean guidelines on good Manufacturing for traditional Medicines.
6. Asean Guidelines’ on Manufacturing Practices for health supplements
7. Us Food & Drug administration 21code of federal regulation part 211.198
8. Manohar A.P: Current good manufacturing practice pharmaceutical-
9. Validation in pharmaceutical industry by P.P. Sharma
10. Pamela Forrest Esq. Partner – king & Spalding :Responding effective to FDA 483 Observation & Warning letters
11. Quality assurance of pharmaceuticals. A compendium of guidelines and related materials, Volume 2. Good manufacturing practices and inspection. Geneva, World Health Organization, 1999.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.